Shih-Yin Chen

Shih-Yin (Sharon) Chen is a seasoned professional in the pharmaceutical industry, currently serving as Senior Director and Head of Neuropsychiatry Franchise within Global Value & Access at Biogen since December 2013. Sharon has played a pivotal role in various leadership capacities, including Change Management Lead and Senior Director of Pipeline Payer & Evidence Strategy, leading diverse teams focused on market access, pricing, reimbursement, and evidence generation. Prior to Biogen, Sharon worked at Evidera in multiple roles including Research Scientist and Senior Manager in Health Economics and Outcomes Research. Sharon holds a PhD in Pharmaceutical Outcomes and Policy from the University of North Carolina at Chapel Hill and a BS in Pharmacy from National Taiwan University.